TY - JOUR
T1 - Inhibition of chlamydial infectious activity due to P2X 7R-dependent phospholipase D activation
AU - Coutinho-Silva, Robson
AU - Stahl, Lynn
AU - Raymond, Marie Noëlle
AU - Jungas, Thomas
AU - Verbeke, Philippe
AU - Burnstock, Geoffrey
AU - Darville, Toni
AU - Ojcius, David M.
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Chlamydia trachomatis survives within host cells by inhibiting fusion between Chlamydia vacuoles and lysosomes. We show here that treatment of infected macrophages with ATP leads to killing of chlamydiae through ligation of the purinergic receptor, P2X7R. Chlamydial killing required phospholipase D (PLD) activation, as PLD inhibition led to rescue of chlamydiae in ATP-treated macrophages. However, there was no PLD activation nor chlamydial killing in ATP-treated P2X7R-deficient macrophages. P2X7R ligation exerts its effects by promoting fusion between Chlamydia vacuoles and lysosomes. P2X7R stimulation also resulted in macrophage death, but fusion with lysosomes preceded macrophage death and PLD inhibition did not prevent macrophage death. These results suggest that P2X7R ligation leads to PLD activation, which is directly responsible for inhibition of infection.
AB - Chlamydia trachomatis survives within host cells by inhibiting fusion between Chlamydia vacuoles and lysosomes. We show here that treatment of infected macrophages with ATP leads to killing of chlamydiae through ligation of the purinergic receptor, P2X7R. Chlamydial killing required phospholipase D (PLD) activation, as PLD inhibition led to rescue of chlamydiae in ATP-treated macrophages. However, there was no PLD activation nor chlamydial killing in ATP-treated P2X7R-deficient macrophages. P2X7R ligation exerts its effects by promoting fusion between Chlamydia vacuoles and lysosomes. P2X7R stimulation also resulted in macrophage death, but fusion with lysosomes preceded macrophage death and PLD inhibition did not prevent macrophage death. These results suggest that P2X7R ligation leads to PLD activation, which is directly responsible for inhibition of infection.
UR - http://www.scopus.com/inward/record.url?scp=0141790831&partnerID=8YFLogxK
U2 - 10.1016/S1074-7613(03)00235-8
DO - 10.1016/S1074-7613(03)00235-8
M3 - 文章
C2 - 14499115
AN - SCOPUS:0141790831
SN - 1074-7613
VL - 19
SP - 403
EP - 412
JO - Immunity
JF - Immunity
IS - 3
ER -